PANTHERx® Specialty Pharmacy Selected by Ultragenyx to Distribute Crysvita

PITTSBURGH, June 7, 2018 /PRNewswire/ --PANTHERx Specialty Pharmacy (PANTHERx), THE Rare Disease Specialty Pharmacy, announced that it has been selected by Ultragenyx Pharmaceutical, Inc. to distribute Crysvita (burosumab-twza), the very first FDA-approved therapy for children and adults with x-linked hypophosphatemia (XLH).